Previous studies have proven that angiopoietin 2 (Ang-2/ANGPT2) can regulate lymphatic vessel development, and mutations in the ANGPT2 gene were recently found in human primary lymphedema (11–13); however, it has not been studied in CMM. This evidence concerns the gene ANGPT2 and familial congenital mirror movements.